Since p130CAS enables FAK to upregulate N-cadherin expression in pancreatic cancer cells, Vu et al. wondered if the flavan-3-ol epigallocatechin-3-gallate (EGCG) could inhibit FAK and reduce N-cadherin expression. This evidence concerns the gene CDH2 and familial pancreatic carcinoma.